[News] Selinexor and dexamethasone in multiple myeloma

Combined treatment with selinexor and dexamethasone shows encouraging activity in patients with highly refractory multiple myeloma, according to a phase 2 trial.

Source: The Lancet Oncology - February 8, 2018 Category: Cancer & Oncology Authors: Talha Khan Burki Tags: News Source Type: research